Increased platelet vesicular monoamine transporter density in adult schizophrenia patients

European Neuropsychopharmacology

Volumn 12, Issue 4, 2002, Pages 343-347

  Zucker, Michal ^a   Valevski, Avi ^a   Weizman, Abraham ^a   Rehavi, Moshe ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Dihydrotetrabenazine; Monoamines; Platelet; Schizophrenia; Vesicular monoamine transporter

Indexed keywords

CARRIER PROTEIN; CLOZAPINE; DIHYDROTETRABENAZINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; LEVOMEPROMAZINE; MONOAMINE; NEUROLEPTIC AGENT; PENFLURIDOL; PERPHENAZINE; RISPERIDONE; TETRABENAZINE; TRITIUM; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER; ZUCLOPENTHIXOL; DRUG DERIVATIVE; MEMBRANE PROTEIN; NEUROPEPTIDE; SLC18A2 PROTEIN, HUMAN; VESICULAR AMINE TRANSPORTER;

ADULT; AMINE TRANSPORT; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MONOAMINERGIC SYSTEM; PRIORITY JOURNAL; SCHIZOPHRENIA; THROMBOCYTE; BINDING COMPETITION; BLOOD; METABOLISM; MIDDLE AGED; PROTEIN BINDING;

ADULT; BINDING, COMPETITIVE; BLOOD PLATELETS; FEMALE; HUMAN; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGE; PROTEIN BINDING; SCHIZOPHRENIA; TETRABENAZINE; TRITIUM; HUMANS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NEUROPEPTIDES; VESICULAR BIOGENIC AMINE TRANSPORT PROTEINS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 0036019865     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(02)00041-X     Document Type: Article

References (27)

1. 3H-imipramine binding in blood platelets of schizophrenic patients
2. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
3. Interactions between monoamines, glutamate and GABA in schizophrenia: new evidence
4. 125I]azidoiodoketanserin photoaffinity labeling of the monoamine transporter of platelet 5-HT organelles
5. The transport of neurotransmitters into synaptic vesicles
6. Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress disorder: preliminary observations on a possible predictor of clinical treatment response
7. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action
8. Drug-resistant schizophrenia-treatment options
9. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
10. +
11. Direct sequencing of the reserpine-sensitive vesicular monoamine transporter complementary DNA in unipolar depression and manic depressive illness
12. Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra
13. Depressed patients have decreased binding of tritiated imipramine to platelet serotonin transporter
14. Vesicular neurotransmitter transport and the presynaptic regulation of quantal size
15. Platelet serotonin transporter in children and adolescents with obsessive-compulsive disorder or Tourette's syndrome
16. Antipsychotic drug doses and neuroleptic/dopamine receptors
17. In vivo measurement of the vesicular monamine transporter in schizophrenia
18. The vesicular monoamine transporter is not regulated by dopaminergic drugs treatment
19. High affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients
20. 3H]imipramine binding in autism and schizophrenia
21. 3H-imipramine binding sites
22. The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat
23. Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia and healthy subjects
24. Changes in vesicular monoamine transporter (VMAT2) and synaptophysin in rat substantia nigra and prefrontal cortex induced by psychotropic drugs
25. 3H]TBZOH binding to the human platelet vesicular monoamine transporter